About 100 reports

  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbidities for NHL

NHL has also been associated with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) infections, such that the relative risk of NHL increases by ##- to ##-fold in HIV/ AIDS patients compared with non-HIV/

  • Lymphoma
  • Japan
  • United States
  • World
  • Forecast

OUR LEAD PROJECT IS A THERAPEUTIC VACCINE FOR HIV.

  • Lymphoma
  • China
  • Celgene Corporation
  • Juno Therapeutics Inc.
  • Novartis AG

OUR LEAD PROJECT IS A THERAPEUTIC VACCINE FOR HIV.

  • Lymphoma
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG

LU, XIONGBIN POLR## A Target CD## NA HIV CD## ##.

  • Lymphoma
  • North America
  • United States
  • Market Size
  • Seattle Genetics, Inc.

Disease Subarachnoid Hemorrhage GVHD Sickle Cell Disease HIV / AIDS ## ##.

  • Lymphoma
  • North America
  • United States
  • Mirati Therapeutics, Inc.
  • Novartis AG
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • European Union
  • Japan
  • United States
  • Roche Group
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • United States
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group
  • Risk Factors and Comorbidities for NHL

NHL HAS ALSO BEEN ASSOCIATED WITH HIV/ ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) INFECTIONS, SUCH THAT THE RELATIVE RISK OF NHL INCREASES BY ##- TO ##-FOLD IN HIV/ AIDS PATIENTS COMPARED WITH NON- HIV/ AIDS PATIENTS (GOEDERT, 2000).

  • Lymphoma
  • United States
  • AbbVie Inc.
  • Novartis AG
  • Roche Group
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • European Union
  • Japan
  • North America
  • United States

A META-ANALYSIS OF THE INCIDENCE OF NON-AIDS CANCERS IN HIV-INFECTED INDIVIDUALS.

  • Lymphoma
  • Affimed Therapeutics AG
  • Incyte Corporation
  • Merck & Co., Inc.
  • Seattle Genetics, Inc.

THIS FEATURE CAN BE USED FOR THE TREATMENT OF PATHOLOGIES SUCH AS HIV/ AIDS MORE THAN ## YEARS AGO, THE TRANSCRIPTION FACTORS WERE OBTAINED FROM THE EGG PROTEIN OF XENOPUSLAEVIS.

  • Lymphoma
  • North America
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017 (CONTD..1), H2 2017
  • selinexor

Exportin ## (Chromosome Region Maintenance ## Protein Homolog or XPO##) - Overview Exportin ## (XPO##) or chromosomal maintenance ## (CRM##) is a eukaryotic protein.

  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • Dedifferentiated Liposarcoma
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..2), H1 2018

SINE compounds demonstrated the ability to potently inhibit HIV replication and tumor growth with the potential for combined treatment of HIV- and AIDS-related cancers such as primary effusion lymphoma (PEL), a Mechanism Of Action Licensing and Collaboration Discovery/ Preclini

  • Cancer
  • Lymphoma
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • Breast Cancer
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2018

It is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL) and HIV-## infections.

  • Lymphoma
  • Therapy
  • China
  • Product Initiative
  • Chipscreen Biosciences Ltd
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H1 2018
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H1 2018

It is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL) and HIV-## infections.

  • Lymphoma
  • Therapy
  • China
  • Product Initiative
  • Chipscreen Biosciences Ltd
  • Human Immunodeficiency Virus (HIV) Infections (AIDS)
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2018 (CONTD..1), H2 2018

It also suppressed HIV-## replication and eliminated the latent infectious state.

  • Lymphoma
  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2018 (CONTD..1), H2 2018
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018 (CONTD..3), H2 2018

It also suppressed HIV-## replication and eliminated the latent infectious state.

  • Lymphoma
  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

AIDS - RELATED CANCER THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2018* As on October 2018, there were one clinical trials in progress and one trials were completed.

  • HIV AIDS
  • Lymphoma
  • Medical Biotechnology
  • World
  • Product Initiative

" We know from decades of work addressing the issue of HIV/ AIDS that there is no one-size-fits-all solution.

  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd ## Jun 2010 ## Aug 2012 ## ## ## ## ## Thymidylate Synthase (TYMS or EC ##. ##. ##. ##) Inhibitor Thymidylate Synthase (TYMS or EC ##. ##. ##. ##) Autologous Transplantation and Stem Cell-Based Gene Therapy with LVsh##/ C## (CAL-##), a Dual Anti-HIV Lentiviral Ve

  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • F. Hoffmann-La Roche Ltd.
  • Metastatic Adenocarcinoma of The Pancreas
  • Breast Cancer

HIV-## reservoir.

  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Syndax Pharmaceuticals, Inc.
  • Target
  • Official Title

Hoffmann-La Roche Ltd ## Aug 2006 ## Nov 2008 ## ## ## ## DNA Polymerase (EC ##. ##. ##. ##) Inhibitor DNA Polymerase (EC ##. ##. ##. ##) A Randomized, Open-label, Crossover Trial of the Effect of High-dose Daily HSV-## Suppressive Therapy on Plasma HIV-## Levels Among HIV-

  • Clinical Trial
  • Infectious Disease
  • Lymphoma
  • Therapy
  • GlaxoSmithKline plc

Fred Fred Hutchinson Cancer Research Center (Fred Hutchinson), a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/ AIDS and other life threatening diseases.

  • Lymphoma
  • Therapy
  • United States
  • Company Operations
  • Juno Therapeutics Inc.
  • 5. All the trials included are unique trials.

AIDS - RELATED PRIMARY CNS LYMPHOMA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN G## COUNTRIES AIDS - RELATED PRIMARY CNS LYMPHOMA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* AIDS - RELATED PRIMARY CNS LYMPHOMA THER

  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • World
  • Product Initiative
  • Epithelial Ovarian Cancer
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H1 2018

IT ALSO PROVIDES SMALL MOLECULE AND PEPTIDE BASED DRUG DISCOVERY CHEMISTRIES AND PRECLINICAL DEVELOPMENT OF NEW DRUGS FOR HUMAN VIRAL DISEASES, CANCER, AIDS AND HEPATITIS C.

  • Breast Cancer
  • Lymphoma
  • United States
  • Product Initiative
  • Syndax Pharmaceuticals, Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2016
  • PIPELINE BY ALTOR BIOSCIENCE CORP, H2 2016

The preliminary results from these collaborations are very encouraging and indicate that ALT-## has substantial potency against a variety of solid tumors as well as HIV infection in experimental models.

  • Immunotherapy
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Altor BioScience Corporation
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Jo

  • Cancer
  • Lymphoma
  • United States
  • World
  • Product Initiative
  • HIV / AIDS
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H1 2016

The company also develops anti-HIV vaccines.

  • Cancer Immunotherapy
  • Lymphoma
  • Oncology
  • Therapy
  • Merck & Co., Inc.
  • ESCHERICHIA COLI INFECTIONS

It also develops drugs for infectious diseases such as influenza, pneumonia, tuberculosis, Lyme disease, HIV/ AIDS et cetera.

  • Hospital
  • Immunotherapy
  • Lymphoma
  • Therapy
  • MediciNova, Inc.
  • Depression
  • Duchenne Muscular Dystrophy

National Institutes of Health. ##-Jul-2015 In July 2015, Tang-Du Hospital registered a Phase I/ II study to evaluate the safety and efficacy of the histone deacetylase inhibitor chidamide in combination with antiretroviral therapy for eradication of the latent HIV-## Reservoir (

  • Lymphoma
  • Therapy
  • United States
  • World
  • Product Initiative